These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2663140)
1. Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. Steen RG Cancer Res; 1989 Aug; 49(15):4075-85. PubMed ID: 2663140 [TBL] [Abstract][Full Text] [Related]
2. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253 [TBL] [Abstract][Full Text] [Related]
3. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. Li SJ; Wehrle JP; Rajan SS; Steen RG; Glickson JD; Hilton J Cancer Res; 1988 Sep; 48(17):4736-42. PubMed ID: 3409214 [TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. Daly PF; Cohen JS Cancer Res; 1989 Feb; 49(4):770-9. PubMed ID: 2643462 [TBL] [Abstract][Full Text] [Related]
5. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
6. Response-specific adriamycin sensitivity markers provided by in vivo 31P nuclear magnetic resonance spectroscopy in murine mammary adenocarcinomas. Evelhoch JL; Keller NA; Corbett TH Cancer Res; 1987 Jul; 47(13):3396-401. PubMed ID: 3581077 [TBL] [Abstract][Full Text] [Related]
7. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245 [TBL] [Abstract][Full Text] [Related]
8. In vivo magnetic resonance imaging and 31P spectroscopy of large human brain tumours at 1.5 tesla. Thomsen C; Jensen KE; Achten E; Henriksen O Acta Radiol; 1988; 29(1):77-82. PubMed ID: 2831923 [TBL] [Abstract][Full Text] [Related]
9. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy. Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784 [TBL] [Abstract][Full Text] [Related]
10. MR spectroscopy of musculoskeletal soft-tissue tumors. Negendank WG Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):713-25. PubMed ID: 8564691 [TBL] [Abstract][Full Text] [Related]
11. Characterization of tumor hypoxia by 31P MR spectroscopy. Steen RG AJR Am J Roentgenol; 1991 Aug; 157(2):243-8. PubMed ID: 1853799 [TBL] [Abstract][Full Text] [Related]
12. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver. Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002 [TBL] [Abstract][Full Text] [Related]
13. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. Winter PM; Poptani H; Bansal N Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759 [TBL] [Abstract][Full Text] [Related]
14. In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors. Procissi D; Claus F; Burgman P; Koziorowski J; Chapman JD; Thakur SB; Matei C; Ling CC; Koutcher JA Clin Cancer Res; 2007 Jun; 13(12):3738-47. PubMed ID: 17575240 [TBL] [Abstract][Full Text] [Related]
15. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. Negendank W; Li CW; Padavic-Shaller K; Murphy-Boesch J; Brown TR Anticancer Res; 1996; 16(3B):1539-44. PubMed ID: 8694523 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo 31P nuclear magnetic resonance measurements of metabolic changes post radiation. Mahmood U; Alfieri AA; Ballon D; Traganos F; Koutcher JA Cancer Res; 1995 Mar; 55(6):1248-54. PubMed ID: 7882317 [TBL] [Abstract][Full Text] [Related]
17. MR spectroscopy of the breast. Merchant TE Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):691-703. PubMed ID: 7489317 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma. Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456 [TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907 [TBL] [Abstract][Full Text] [Related]
20. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study. Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]